# EDGAR Filing Document

**Accession Number:** 0002100782
**File Stem:** 9999999995-26-000677
**Filing Date:** 2026-2
**Character Count:** 1297
**Document Hash:** 823eec0d1f6f2d38608818cb860d0d52
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-000677.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 9999999995-26-000677

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260227

**EFFECTIVENESS DATE**: 20260226

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Generate Biomedicines, Inc.
- **CENTRAL INDEX KEY:** 0002100782
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 831630228
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293204
- **FILM NUMBER:** 26692324

**BUSINESS ADDRESS:**
- **STREET 1:** 101 SOUTH STREET, SUITE 900
- **CITY:** SOMERVILLE
- **STATE:** MA
- **ZIP:** 02143
- **BUSINESS PHONE:** 888-469-0055

**MAIL ADDRESS:**
- **STREET 1:** 101 SOUTH STREET, SUITE 900
- **CITY:** SOMERVILLE
- **STATE:** MA
- **ZIP:** 02143

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** February 26, 2026

**Time:** 16:30:00

**Form Type:** S-1

---

**CIK:** 0002100782

**Company Name:** Generate Biomedicines, Inc.

**File Number:** 333-293204